Reported relationships
Latest disclosed role at each company.
| Company | Last reported as | Report date | Published |
|---|---|---|---|
| PepGen Inc.PEPG · Entity 6253 | Chief Financial Officer | March 04, 2026 | March 06, 2026 |
| Radiopharm Theranostics LtdRADX · Entity 7436 | Director | March 18, 2026 | April 01, 2026 |
Disclosed balances
About these balances
Latest available filing per company, not a reconstructed current portfolio. Matching sequences show the last reported balance with all source rows expandable; grouping alone does not establish account ownership. Do not add unresolved positions together. Filings may omit unchanged positions, and amendments may correct only part of an older disclosure. Jointly reported shares are not necessarily this owner's personal holdings.
PepGen Inc.
Report date March 04, 2026 · Filed March 06, 2026
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Common StockSEC Table I · non-derivative | Direct | 111,603 |
Ending reported balance
After 2026-03-04 transaction · row 2
2 source rows · reconciled sequenceRow 1 · 2026-03-04 · Sale · Disposed 2,032 · Balance 111,655 F1: Represents shares automatically sold by the Company on behalf of the Reporting Person pursuant to a mandatory sell-to-cover provision in the award agreement required to cover minimum statutory tax withholding obligations that became due upon the vesting and settlement of restricted stock units ("RSUs"). The mandatory sale of the Reporting Person's shares was provided for in a RSU agreement constituting a "binding contract" consistent with the affirmative defense to liability under Rule 10b5-1 and the sale does not represent a discretionary trade by the Reporting Person. Row 2 · 2026-03-04 · Sale · Disposed 52 · Balance 111,603 F1: Represents shares automatically sold by the Company on behalf of the Reporting Person pursuant to a mandatory sell-to-cover provision in the award agreement required to cover minimum statutory tax withholding obligations that became due upon the vesting and settlement of restricted stock units ("RSUs"). The mandatory sale of the Reporting Person's shares was provided for in a RSU agreement constituting a "binding contract" consistent with the affirmative defense to liability under Rule 10b5-1 and the sale does not represent a discretionary trade by the Reporting Person. |
Filing footnotes · ownership attribution and instrument terms
F1: Represents shares automatically sold by the Company on behalf of the Reporting Person pursuant to a mandatory sell-to-cover provision in the award agreement required to cover minimum statutory tax withholding obligations that became due upon the vesting and settlement of restricted stock units ("RSUs"). The mandatory sale of the Reporting Person's shares was provided for in a RSU agreement constituting a "binding contract" consistent with the affirmative defense to liability under Rule 10b5-1 and the sale does not represent a discretionary trade by the Reporting Person.
Radiopharm Theranostics Ltd
Report date March 18, 2026 · Filed April 01, 2026
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Option (right to buy)SEC Table II · derivative / convertible security · Conversion / exercise price $0.06 · Expires 2029-09-30 | Direct | Not disclosed |
Reported balance
Holding disclosure · report date 2026-03-18 · row 1
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 1 · Balance Not disclosed |
| Option (right to buy)SEC Table II · derivative / convertible security · Conversion / exercise price $0.06 · Expires 2029-09-30 | Direct | Not disclosed |
Reported balance
Holding disclosure · report date 2026-03-18 · row 2
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 2 · Balance Not disclosed F1: Granted on December 16, 2024. 2,666,667 options will vest on September 30, 2026 and 2,666,666 options will vest on September 30, 2027 provided Mr. Donnelly is still a Director on such dates. |
Filing footnotes · ownership attribution and instrument terms
F1: Granted on December 16, 2024. 2,666,667 options will vest on September 30, 2026 and 2,666,666 options will vest on September 30, 2027 provided Mr. Donnelly is still a Director on such dates.
Transaction history
JSON APIPurchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Company | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| March 04, 2026 Filed Mar 6, 2026 16:12 UTC | PepGen Inc. PEPG · Entity 6253 | SaleCommon Stock | 52 | $6.33 | $328.90 |
DisclosureSEC source: 0001835597-26-000014 · form4.xml · nonDerivative · entry 2 Donnelly Noel · CIK 0001922546 · Chief Financial Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 111,603 F1 · kind: Represents shares automatically sold by the Company on behalf of the Reporting Person pursuant to a mandatory sell-to-cover provision in the award agreement required to cover minimum statutory tax withholding obligations that became due upon the vesting and settlement of restricted stock units ("RSUs"). The mandatory sale of the Reporting Person's shares was provided for in a RSU agreement constituting a "binding contract" consistent with the affirmative defense to liability under Rule 10b5-1 and the sale does not represent a discretionary trade by the Reporting Person. Read SEC document |
| March 04, 2026 Filed Mar 6, 2026 16:12 UTC | PepGen Inc. PEPG · Entity 6253 | SaleCommon Stock | 2,032 | $6.23 | $12,659.36 |
DisclosureSEC source: 0001835597-26-000014 · form4.xml · nonDerivative · entry 1 Donnelly Noel · CIK 0001922546 · Chief Financial Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 111,655 F1 · kind: Represents shares automatically sold by the Company on behalf of the Reporting Person pursuant to a mandatory sell-to-cover provision in the award agreement required to cover minimum statutory tax withholding obligations that became due upon the vesting and settlement of restricted stock units ("RSUs"). The mandatory sale of the Reporting Person's shares was provided for in a RSU agreement constituting a "binding contract" consistent with the affirmative defense to liability under Rule 10b5-1 and the sale does not represent a discretionary trade by the Reporting Person. Read SEC document |
| March 01, 2026 Filed Mar 2, 2026 17:02 UTC | PepGen Inc. PEPG · Entity 6253 | GrantStock Option (Right to Buy) · Derivative | 300,000 | $0.00 Strike: $6.22 | $0.00 |
DisclosureSEC source: 0001835597-26-000004 · form4.xml · derivative · entry 2 Donnelly Noel · CIK 0001922546 · Chief Financial Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 300,000 Underlying: Common Stock · 300,000 shares Expires 2036-02-29 F3 · derivative.exercise_date: This option shall vest and become exercisable as follows: 25% of the shares on the one-year anniversary of the Grant Date, with the remaining 75% vesting and becoming exercisable in 36 equal monthly installments thereafter, subject to the Reporting Person's continued service to the Issuer on each such vesting date. Read SEC document |
| March 01, 2026 Filed Mar 2, 2026 17:02 UTC | PepGen Inc. PEPG · Entity 6253 | GrantCommon Stock | 76,793 | $0.00 | $0.00 |
DisclosureSEC source: 0001835597-26-000004 · form4.xml · nonDerivative · entry 1 Donnelly Noel · CIK 0001922546 · Chief Financial Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 113,687 F1 · shares: Consists of 76,793 restricted stock units ("RSUs"), each representing the contingent right to receive one share of Common Stock upon vesting. The RSUs vest in equal annual installments over four years, with the first installment vesting on March 1, 2027, subject to the Reporting Person's continued service to the Issuer on each such vesting date. F2 · balance_after: Includes 11,938 shares acquired under the PepGen Inc. 2022 Employee Stock Purchase Plan on November 28, 2025 in a transaction that was exempt under Rule 16b-3(c). Read SEC document |
| November 04, 2025 Filed Dec 18, 2025 15:28 UTC | PepGen Inc. PEPG · Entity 6253 | GrantStock Option (Right to Buy) · Derivative | 144,000 | $0.00 Strike: $4.53 | $0.00 |
DisclosureSEC source: 0001835597-25-000013 · form4.xml · derivative · entry 8 Donnelly Noel · CIK 0001922546 · Chief Financial Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 144,000 Underlying: Common Stock · 144,000 shares Expires 2034-02-28 F1 · kind: On November 4, 2025, the Issuer's Board of Directors approved a repricing of the Reporting Person's outstanding stock options granted under the Issuer's 2020 Stock Plan, 2022 Stock Option and Incentive Plan, and 2024 Inducement Plan. The exercise price of eligible options was reduced to $4.53, with all other terms unchanged except that the reduced exercise price is available only if the Reporting Person satisfies the applicable retention period; otherwise, the original exercise price will apply. The transactions reported herein are exempt pursuant to Rules 16b-6(d) and 16b-3 under the Securities Exchange Act of 1934. F3 · derivative.exercise_date: This option shall vest as follows: twenty-five percent (25%) on the one-year anniversary of the Grant Date and the remainder vesting in thirty-six (36) equal monthly installments, subject to the option recipient's continued service or employment with the Company on each applicable vesting date. Read SEC document |
| November 04, 2025 Filed Dec 18, 2025 15:28 UTC | PepGen Inc. PEPG · Entity 6253 | Disposition to issuerStock Option (Right to Buy) · Derivative | 144,000 | $0.00 Strike: $16.62 | $0.00 |
DisclosureSEC source: 0001835597-25-000013 · form4.xml · derivative · entry 7 Donnelly Noel · CIK 0001922546 · Chief Financial Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 144,000 shares Expires 2034-02-28 F1 · kind: On November 4, 2025, the Issuer's Board of Directors approved a repricing of the Reporting Person's outstanding stock options granted under the Issuer's 2020 Stock Plan, 2022 Stock Option and Incentive Plan, and 2024 Inducement Plan. The exercise price of eligible options was reduced to $4.53, with all other terms unchanged except that the reduced exercise price is available only if the Reporting Person satisfies the applicable retention period; otherwise, the original exercise price will apply. The transactions reported herein are exempt pursuant to Rules 16b-6(d) and 16b-3 under the Securities Exchange Act of 1934. F3 · derivative.exercise_date: This option shall vest as follows: twenty-five percent (25%) on the one-year anniversary of the Grant Date and the remainder vesting in thirty-six (36) equal monthly installments, subject to the option recipient's continued service or employment with the Company on each applicable vesting date. Read SEC document |
| November 04, 2025 Filed Dec 18, 2025 15:28 UTC | PepGen Inc. PEPG · Entity 6253 | GrantStock Option (Right to Buy) · Derivative | 144,000 | $0.00 Strike: $4.53 | $0.00 |
DisclosureSEC source: 0001835597-25-000013 · form4.xml · derivative · entry 6 Donnelly Noel · CIK 0001922546 · Chief Financial Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 144,000 Underlying: Common Stock · 144,000 shares Expires 2033-02-28 F1 · kind: On November 4, 2025, the Issuer's Board of Directors approved a repricing of the Reporting Person's outstanding stock options granted under the Issuer's 2020 Stock Plan, 2022 Stock Option and Incentive Plan, and 2024 Inducement Plan. The exercise price of eligible options was reduced to $4.53, with all other terms unchanged except that the reduced exercise price is available only if the Reporting Person satisfies the applicable retention period; otherwise, the original exercise price will apply. The transactions reported herein are exempt pursuant to Rules 16b-6(d) and 16b-3 under the Securities Exchange Act of 1934. F3 · derivative.exercise_date: This option shall vest as follows: twenty-five percent (25%) on the one-year anniversary of the Grant Date and the remainder vesting in thirty-six (36) equal monthly installments, subject to the option recipient's continued service or employment with the Company on each applicable vesting date. Read SEC document |
| November 04, 2025 Filed Dec 18, 2025 15:28 UTC | PepGen Inc. PEPG · Entity 6253 | Disposition to issuerStock Option (Right to Buy) · Derivative | 144,000 | $0.00 Strike: $15.25 | $0.00 |
DisclosureSEC source: 0001835597-25-000013 · form4.xml · derivative · entry 5 Donnelly Noel · CIK 0001922546 · Chief Financial Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 144,000 shares Expires 2033-02-28 F1 · kind: On November 4, 2025, the Issuer's Board of Directors approved a repricing of the Reporting Person's outstanding stock options granted under the Issuer's 2020 Stock Plan, 2022 Stock Option and Incentive Plan, and 2024 Inducement Plan. The exercise price of eligible options was reduced to $4.53, with all other terms unchanged except that the reduced exercise price is available only if the Reporting Person satisfies the applicable retention period; otherwise, the original exercise price will apply. The transactions reported herein are exempt pursuant to Rules 16b-6(d) and 16b-3 under the Securities Exchange Act of 1934. F3 · derivative.exercise_date: This option shall vest as follows: twenty-five percent (25%) on the one-year anniversary of the Grant Date and the remainder vesting in thirty-six (36) equal monthly installments, subject to the option recipient's continued service or employment with the Company on each applicable vesting date. Read SEC document |
| November 04, 2025 Filed Dec 18, 2025 15:28 UTC | PepGen Inc. PEPG · Entity 6253 | GrantStock Option (Right to Buy) · Derivative | 169,037 | $0.00 Strike: $4.53 | $0.00 |
DisclosureSEC source: 0001835597-25-000013 · form4.xml · derivative · entry 4 Donnelly Noel · CIK 0001922546 · Chief Financial Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 169,037 Underlying: Common Stock · 169,037 shares Expires 2032-05-05 F1 · kind: On November 4, 2025, the Issuer's Board of Directors approved a repricing of the Reporting Person's outstanding stock options granted under the Issuer's 2020 Stock Plan, 2022 Stock Option and Incentive Plan, and 2024 Inducement Plan. The exercise price of eligible options was reduced to $4.53, with all other terms unchanged except that the reduced exercise price is available only if the Reporting Person satisfies the applicable retention period; otherwise, the original exercise price will apply. The transactions reported herein are exempt pursuant to Rules 16b-6(d) and 16b-3 under the Securities Exchange Act of 1934. F3 · derivative.exercise_date: This option shall vest as follows: twenty-five percent (25%) on the one-year anniversary of the Grant Date and the remainder vesting in thirty-six (36) equal monthly installments, subject to the option recipient's continued service or employment with the Company on each applicable vesting date. Read SEC document |
| November 04, 2025 Filed Dec 18, 2025 15:28 UTC | PepGen Inc. PEPG · Entity 6253 | Disposition to issuerStock Option (Right to Buy) · Derivative | 169,037 | $0.00 Strike: $12.00 | $0.00 |
DisclosureSEC source: 0001835597-25-000013 · form4.xml · derivative · entry 3 Donnelly Noel · CIK 0001922546 · Chief Financial Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 169,037 shares Expires 2032-05-05 F1 · kind: On November 4, 2025, the Issuer's Board of Directors approved a repricing of the Reporting Person's outstanding stock options granted under the Issuer's 2020 Stock Plan, 2022 Stock Option and Incentive Plan, and 2024 Inducement Plan. The exercise price of eligible options was reduced to $4.53, with all other terms unchanged except that the reduced exercise price is available only if the Reporting Person satisfies the applicable retention period; otherwise, the original exercise price will apply. The transactions reported herein are exempt pursuant to Rules 16b-6(d) and 16b-3 under the Securities Exchange Act of 1934. F3 · derivative.exercise_date: This option shall vest as follows: twenty-five percent (25%) on the one-year anniversary of the Grant Date and the remainder vesting in thirty-six (36) equal monthly installments, subject to the option recipient's continued service or employment with the Company on each applicable vesting date. Read SEC document |
| November 04, 2025 Filed Dec 18, 2025 15:28 UTC | PepGen Inc. PEPG · Entity 6253 | GrantStock Option (Right to Buy) · Derivative | 203,339 | $0.00 Strike: $4.53 | $0.00 |
DisclosureSEC source: 0001835597-25-000013 · form4.xml · derivative · entry 2 Donnelly Noel · CIK 0001922546 · Chief Financial Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 203,339 Underlying: Common Stock · 203,339 shares Expires 2031-11-10 F1 · kind: On November 4, 2025, the Issuer's Board of Directors approved a repricing of the Reporting Person's outstanding stock options granted under the Issuer's 2020 Stock Plan, 2022 Stock Option and Incentive Plan, and 2024 Inducement Plan. The exercise price of eligible options was reduced to $4.53, with all other terms unchanged except that the reduced exercise price is available only if the Reporting Person satisfies the applicable retention period; otherwise, the original exercise price will apply. The transactions reported herein are exempt pursuant to Rules 16b-6(d) and 16b-3 under the Securities Exchange Act of 1934. F2 · derivative.exercise_date: This stock option vests over four years following the vesting commencement date (October 15, 2021) with 25% of such shares vesting on the first anniversary of the vesting commencement date, and the remaining shares vesting in 36 equal monthly installments, subject to continued service through each vesting date. Read SEC document |
| November 04, 2025 Filed Dec 18, 2025 15:28 UTC | PepGen Inc. PEPG · Entity 6253 | Disposition to issuerStock Option (Right to Buy) · Derivative | 203,339 | $0.00 Strike: $10.88 | $0.00 |
DisclosureSEC source: 0001835597-25-000013 · form4.xml · derivative · entry 1 Donnelly Noel · CIK 0001922546 · Chief Financial Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 203,339 shares Expires 2031-11-10 F1 · kind: On November 4, 2025, the Issuer's Board of Directors approved a repricing of the Reporting Person's outstanding stock options granted under the Issuer's 2020 Stock Plan, 2022 Stock Option and Incentive Plan, and 2024 Inducement Plan. The exercise price of eligible options was reduced to $4.53, with all other terms unchanged except that the reduced exercise price is available only if the Reporting Person satisfies the applicable retention period; otherwise, the original exercise price will apply. The transactions reported herein are exempt pursuant to Rules 16b-6(d) and 16b-3 under the Securities Exchange Act of 1934. F2 · derivative.exercise_date: This stock option vests over four years following the vesting commencement date (October 15, 2021) with 25% of such shares vesting on the first anniversary of the vesting commencement date, and the remaining shares vesting in 36 equal monthly installments, subject to continued service through each vesting date. Read SEC document |
| March 03, 2025 Filed Mar 5, 2025 17:33 UTC | PepGen Inc. PEPG · Entity 6253 | GrantStock Option (Right to Buy) · Derivative | 104,250 | $0.00 Strike: $2.81 | $0.00 |
DisclosureSEC source: 0001127602-25-008366 · form4.xml · derivative · entry 2 Donnelly Noel · CIK 0001922546 · Chief Financial Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 104,250 Underlying: Common Stock · 104,250 shares Expires 2035-03-02 F3 · derivative.exercise_date: This option shall vest as follows: twenty-five percent (25%) on the one-year anniversary of the Grant Date and the remainder vesting in thirty-six (36) equal monthly installments, subject to the Reporting Person's continued service or employment with the Company on each applicable vesting date. Read SEC document |
| March 03, 2025 Filed Mar 5, 2025 17:33 UTC | PepGen Inc. PEPG · Entity 6253 | GrantCommon Stock | 23,283 | $0.00 | $0.00 |
DisclosureSEC source: 0001127602-25-008366 · form4.xml · nonDerivative · entry 1 Donnelly Noel · CIK 0001922546 · Chief Financial Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 24,956 F1 · shares: Consists of shares of Common Stock issuable under 23,283 restricted stock units ("RSUs"). Each RSU represents the right to receive one share of Common Stock upon vesting. These RSUs are scheduled to vest in equal annual installments over four years with the first installment vesting on March 3, 2026, subject to the Reporting Person's continued service or employment with the Company on each applicable vesting date. F2 · balance_after: Includes of 23,283 shares of unvested RSUs. Read SEC document |
| February 26, 2025 Filed Feb 26, 2025 20:12 UTC | PepGen Inc. PEPG · Entity 6253 | SaleCommon Stock | 1,527 | $1.68 | $2,565.36 |
DisclosureSEC source: 0001127602-25-006999 · form4.xml · nonDerivative · entry 2 Donnelly Noel · CIK 0001922546 · Chief Financial Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 1,673 F2 · kind: Represents shares automatically sold by the Company on behalf of the Reporting Person pursuant to a mandatory sell-to-cover provision in the award agreement required to cover minimum statutory tax withholding obligations that became due upon the vesting and settlement of the PSUs reported in this form. The mandatory sale of the Reporting Person's shares was provided for in a PSU agreement constituting a "binding contract" consistent with the affirmative defense to liability under Rule 10b5-1 and the sale does not represent a discretionary trade by the Reporting Person. Read SEC document |
| February 24, 2025 Filed Feb 26, 2025 20:12 UTC | PepGen Inc. PEPG · Entity 6253 | GrantCommon Stock | 3,200 | $0.00 | $0.00 |
DisclosureSEC source: 0001127602-25-006999 · form4.xml · nonDerivative · entry 1 Donnelly Noel · CIK 0001922546 · Chief Financial Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 3,200 F1 · shares: On February 6, 2024, the Reporting Person was granted performance-based stock units ("PSUs") under the 2022 Stock Option and Incentive Plan. Each PSU represents the right to receive one share of Common Stock upon vesting. The shares reported were issued to the Reporting Person upon achievement of a performance condition on February 24, 2025, as determined by the Compensation Committee of the Company's Board of Directors. Read SEC document |
| March 01, 2024 Filed Mar 1, 2024 17:33 UTC | PepGen Inc. PEPG · Entity 6253 | GrantStock Option (Right to Buy) · Derivative | 144,000 | $0.00 Strike: $16.62 | $0.00 |
DisclosureSEC source: 0001127602-24-007950 · form4.xml · derivative · entry 1 Donnelly Noel · CIK 0001922546 · Chief Financial Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 144,000 Underlying: Common Stock · 144,000 shares Expires 2034-02-28 F1 · derivative.exercise_date: This option shall vest as follows: twenty-five percent (25%) on the one-year anniversary of the Grant Date and the remainder vesting in thirty-six (36) equal monthly installments, subject to the option recipient's continued service or employment with the Company on each applicable vesting date. Read SEC document |
| March 01, 2023 Filed Mar 2, 2023 16:33 UTC | PepGen Inc. PEPG · Entity 6253 | GrantStock Option (Right to Buy) · Derivative | 144,000 | $0.00 Strike: $15.25 | $0.00 |
DisclosureSEC source: 0001127602-23-008373 · form4.xml · derivative · entry 1 Donnelly Noel · CIK 0001922546 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 144,000 Underlying: Common Stock · 144,000 shares Expires 2033-02-28 F1 · derivative.exercise_date: This option shall vest as follows: twenty-five percent (25%) on the one-year anniversary of the Grant Date and the remainder vesting in thirty-six (36) equal monthly installments, subject to the option recipient's continued service or employment with the Company on each applicable vesting date. Read SEC document |
| May 06, 2022 Filed May 10, 2022 18:46 UTC | PepGen Inc. PEPG · Entity 6253 | GrantStock Option (Right to Buy) · Derivative | 169,037 | $0.00 Strike: $12.00 | $0.00 |
DisclosureSEC source: 0000899243-22-017492 · doc4.xml · derivative · entry 1 Donnelly Noel · CIK 0001922546 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 169,037 Underlying: Common Stock · 169,037 shares Expires 2032-05-05 F1 · derivative.exercise_date: This option shall vest as follows: twenty-five percent (25%) on the one-year anniversary of the Grant Date and the remainder vesting in thirty-six (36) equal monthly installments, subject to the option recipient's continued service or employment with the Company on each applicable vesting date. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.